Interaction of stroma and tumor cells within a carcinoma can influence tumor growth and progression. We investigated possible influences of allogeneic and autologous fibroblasts on established squamous cell head and neck carcinoma lines (SCHNCL) and freshly isolated cells from such tumors. Tumor cells were compared in their colony-forming ability, starting from low cell counts, in their ability to form multicellular spheroids (MCS) and in their capacity to form tumors in the subrenal capsule of nu/nu mice. All tumor cell lines tested had a weak plating efficiency, whereas the capacity to form MCS as well as growth and progression in the xenotransplantation model showed large differences. The fibroblasts produced soluble factor(s) which increased colony formation of all tumor cell lines tested to the same extent, whereas admixture of fibroblasts exhibited a different influence on the MCS size and growth. They accelerated growth of the slowly growing MCS but did hardly alter growth of the fast growing ones. Tumor cells growing invasively in the xenotransplantation model were not influenced by coinoculation with fibroblasts; other tumor cells did not produce detectable tumors in nude mice or formed nodules well separated from the renal tissue: adding fibroblasts to these cells caused invasive growth of xenografts. The growth-promoting effects of fibroblasts in these extracorporeal systems might be of prognostic or even therapeutic benefit if intervention of these properties were successful.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.